Lilly Announces a Call for Articles Into 2007 Luminous Award

Indianapolis (ots/PRNewswire) -

- Luminous Award recognizes outstanding cancer journalism from
outlets around the world

Following the success of the inaugural Luminous Award in 2006,
Lilly Oncology announced today the call for entries to Luminous 2007.
The Luminous Award was created by Lilly to honour journalism that
serves readers and viewers by providing responsible, accurate and
timely information on advances in cancer prevention, research,
development and treatment.

Open to all journalists reporting for newspapers, consumer
magazines, newsletters, websites and broadcast outlets, entries are
judged on a series of criteria including news value, the ability to
stimulate awareness about advances in oncology, effective
communication for the intended audience and creativity. The closing
deadline for entries is 1 September 2007, and the winner will be
announced during the European Conference on Clinical Oncology (ECCO),
23 - 27 September 2007.

The winner of the Luminous Award will have the opportunity to
choose a seven-day trip for two people to Boston, London, New York,
Paris or Sydney, to be enlightened by the work of a world-renowned
oncologist or cancer researcher.

As an alternative to the trip, the winner may choose a cash
donation of euro 10,000 made in the form of a scholarship, in their
name, to help a student continue his or her studies to become a
journalist and enlighten others through his or her work.

There will also be a runner-up prize of five days for two to
either London or New York where he or she will have the opportunity
to meet with a world-renowned oncologist or cancer researcher who
will share their insights. Alternatively, the runner-up may select a
cash donation of euro 5,000 made in the form of a scholarship, in
their name, to help a student continue his or her studies to become a
journalist and enlighten others through his or her work.

Certain local restrictions may apply regarding this Journalism
Award and it is only available where not prohibited or restricted by
local laws and regulations.

For further information and an entry form, please contact:
Gina Worthington Christine Van Marter
Luminous Award Secretariat Eli Lilly and Company
Tel: +44-207-395-7180 Tel: +1-317-651-1473
Fax: +44-207-395-7101 Email: vanmarterch@lilly.com
E-mail: luminousaward@cprworldwide.com

About Lilly Oncology, a Division of Eli Lilly and Company

For more than four decades, Lilly Oncology has been collaborating
with cancer researchers to deliver innovative treatment choices and
valuable programs to patients and physicians worldwide. Inspired by
the courageous patients living with cancer, Lilly Oncology is
providing treatments that are considered global standards of care and
developing a broad portfolio of novel targeted therapies to
accelerate the pace and progress of cancer care.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a
growing portfolio of first-in-class and best-in-class pharmaceutical
products by applying the latest research from its own worldwide
laboratories and from collaborations with eminent scientific
organizations. Headquartered in Indianapolis, Ind., Lilly provides
answers -- through medicines and information -- for some of the
world's most urgent medical needs.

O-LLY

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO
http://www.newscom.com/cgi-bin/prnh/20070601/CLF003LOGO )

ots Originaltext: Eli Lilly and Company
Im Internet recherchierbar: http://www.presseportal.de

Contact:
Christine Van Marter, of Eli Lilly and Company, +1-317-651-1473,
CHRISTINE_VAN_MARTER@lilly.com . NewsCom:
http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO,
http://www.newscom.com/cgi-bin/prnh/20070601/CLF003LOGO , PRN Photo
Desk, photodesk@prnewswire.com